Login / Signup

Ethical and procedural issues for applying researcher-driven multi-national paediatric clinical trials in and outside the European Union: the challenging experience of the DEEP project.

Viviana GiannuzziMariagrazia FelisiDonato BonifaziHugo DevliegerGeorge PapanikolaouLamis RagabSlaheddine FattoumBianca TempestaGiorgio ReggiardoAdriana Ceci
Published in: BMC medical ethics (2021)
This work confirms that the procedures and requirements for the clinical trial application of a paediatric trial are different. In the European Union, the timeframes for submission were generally harmonised but longer. In non-European countries, delays were caused by national dispositions but the entire authorisation process resulted faster with less requests from ECs/CAs. The upcoming application of Regulation (EU) 536/2014 is expected to harmonise practices in Europe and possibly outside. Networks on paediatric research acting at international level will be crucial in this effort.
Keyphrases
  • clinical trial
  • quality improvement
  • intensive care unit
  • phase ii
  • emergency department
  • phase iii
  • study protocol
  • healthcare
  • primary care
  • crispr cas
  • open label
  • double blind
  • randomized controlled trial